Increasing adiposity in normal ovulatory women affects adipocytokine expression in subcutaneous and visceral abdominal fat

International Journal of Gynecology and Obstetrics

Volumn 104, Issue 2, 2009, Pages 121-124

  Vardhana, Pratibhasri A ^a   Dicken, Cary ^a   Tortoriello, Drew V ^a   Chu, Michelene ^a   Carmina, Enrico ^a   Lobo, Rogerio A ^a  

^a Department of Medicine   (United States)

Author keywords

Adipocytokines; Adiponectin; Body mass index; Leptin; Ovulatory

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; INTERLEUKIN 6; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL SUBCUTANEOUS FAT; ADULT; ARTICLE; BLOOD LEVEL; BODY MASS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; GYNECOLOGIC SURGERY; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID STORAGE; OBESITY; OVULATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 58149260351     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2008.10.006     Document Type: Article

References (25)

1. Centers for Disease Control and Prevention. http://www.cdc.gov.
2. World Health Orgaization. Obesity: Preventing and managing the global epidemic (1998), WHO, Geneva Technical Report Series 894
3. Ryan D. Obesity in women: A life cycle of medical risk. Int J Obes 31 Suppl 2 (2007) S3-S7
4. Kershaw E.E., and Flier J.S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89 6 (2004) 2548-2556
5. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., and Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 372 6505 (1994) 425-432
6. Goldstein B.J., and Scalia R. Adiponectin: A novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 89 6 (2004) 2563-2568
7. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 1 (1999) 79-83
8. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., et al. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86 5 (2001) 1930-1935
9. Hyun Y.J., Koh S.J., Chae J.S., Kim J.Y., Kim O.Y., Lim H.H., et al. Atherogenecity of LDL and unfavorable adipokine profile in metabolically obese, normal-weight woman. Obesity 16 4 (Silver Spring 2008) 784-789
10. Lihn A.S., Bruun J.M., He G., Pedersen S.B., Jensen P.F., and Richelsen B. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 219 1-2 (2004) 9-15
11. Bjorbaek C., and Kahn B.B. Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 59 (2004) 305-331
12. Fain J.N., Madan A.K., Hiler M.L., Cheema P., and Bahouth S.W. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 145 5 (2004) 2273-2282
13. Guzik T.J., Mangalat D., and Korbut R. Adipocytokines - novel link between inflammation and vascular function?. J Physiol Pharmacol 57 4 (2006) 505-528
14. Reece E.A. Perspectives on obesity, pregnancy and birth outcomes in the united states: The scope of the problem. Am J Obstet Gynecol 198 1 (2008) 23-27
15. Guerre-Millo M. Adipose tissue and adipokines: For better or worse. Diabetes Metab 30 1 (Feb 2004) 13-19
16. Degawa-Yamauchi M., Moss K.A., Bovenkerk J.E., Shankar S.S., Morrison C.L., Lelliott C.J., et al. Regulation of adiponectin expression in human adipocytes: Effects of adiposity, glucocorticoids, and tumor necrosis factor alpha. Obes Res 13 4 (2005) 662-669
17. Dusserre E., Moulin P., and Vidal H. Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Biochim Biophys Acta 1500 1 (2000) 88-96
18. Hube F., Lietz U., Igel M., Jensen P.B., Tornqvist H., Joost H.G., et al. Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans. Horm Metab Res 28 12 (1996) 690-693
19. Kern P.A., Di Gregorio G.B., Lu T., Rassouli N., and Ranganathan G. Adiponectin expression from human adipose tissue: Relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 52 7 (2003) 1779-1785
20. Schoof E., Stuppy A., Harig F., Carbon R., Horbach T., Stohr W., et al. Comparison of leptin gene expression in different adipose tissues in children and adults. Eur J Endocrinol 150 4 (2004) 579-584
21. Walker G.E., Verti B., Marzullo P., Savia G., Mencarelli M., Zurleni F., et al. Deep subcutaneous adipose tissue: A distinct abdominal adipose depot. Obesity 15 8 (Silver Spring 2007) 1933-1943
22. Carmina E., Chu M.C., Moran C., Tortoriello D., Vardhana P., Tena G., et al. Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome. Fertil Steril 89 3 (2008) 642-648
23. Kumagai S., Kishimoto H., Masatakasuwa, and Zou B. The leptin to adiponectin ratio is a good biomarker for the prevalence of metabolic syndrome, dependent on visceral fat accumulation and endurance fitness in obese patients with diabetes mellitus. Metab Syndr Relat Disord 3 2 (2005) 85-94
24. Kotani K., and Sakane N. Leptin-to-adiponectin ratio as a new marker associated with metabolic disease. [in Japanese]. Nippon Rinsho 64 Suppl 9 (2006) 540-543
25. Oda N., Imamura S., Fujita T., Uchida Y., Inagaki K., Kakizawa H., et al. The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metabolism 57 2 (2008) 268-273